How does GRDN's Q4 2024 performance compare to forecasts?

Guardian Pharmacy Services, Inc. (GRDN) reported its Q4 2024 financial results, and we have compared its performance with the forecasts as follows:

1. **Revenue Comparison**:
- GRDN's Total Revenue for Q4 2024 was $338.57 million.
- The total revenue was higher than the expected $332.77 million.
- This indicates a positive variance of $5.80 million or approximately 1.75% compared to forecasts.

|code|Ticker|Name|Date|Total Revenue|Net Income|Diluted EPS|market_code|
|---|---|---|---|---|---|---|---|
|GRDN|GRDN.N|Guardian Pharmacy|2024 Q2|3.00037E8|1.5848E7||169|
|GRDN|GRDN.N|Guardian Pharmacy|2024 Q3|3.14393E8|-1.05817E8|-2|169|
|GRDN|GRDN.N|Guardian Pharmacy|2024 Q4|3.38569E8|1.1841E7||169|

2. **Earnings Comparison**:
- GRDN reported a Net Income of $11.84 million for Q4 2024.
- The company's Adjusted Earnings Per Share (EPS) was $0.19 for the quarter.
- Analysts had expected an EPS of $0.16 for the quarter.
- This indicates a positive variance of $0.03 per share or approximately 19% compared to forecasts.
3. **Growth Rates**:
- GRDN experienced a Net Income Growth Rate of 269.28%.
- The Total Revenue Growth Rate was 28.86%.
- These significant growth rates suggest that GRDN has outperformed expectations in terms of profitability and revenue expansion.

In conclusion, Guardian Pharmacy Services, Inc. (GRDN) has exceeded market forecasts in both revenue and earnings for Q4 2024. The company's strong financial performance, especially in net income and revenue growth, reflects its successful business strategies and operational efficiency.